Xbrane Biopharma AB (XBRANE) — Cash Flow Quality Index

Latest as of June 2025: -0.38x

Xbrane Biopharma AB (XBRANE) has a Cash Flow Quality Index of -0.38x as of June 2025. Operating cash flow of Skr-65.06 Million is below net income of Skr171.81 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Xbrane Biopharma AB balance sheet assets for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.38x

Operating CF / Net Income

Operating Cash Flow

Skr-65.06 Million

SEK

Net Income

Skr171.81 Million

SEK

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for Xbrane Biopharma AB (None–None)

Year-by-year earnings quality comparison for Xbrane Biopharma AB. For live market cap and the full company financial profile, see XBRANE market cap.

Year	Quality Index	Operating CF (SEK)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.